{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:48:07Z","timestamp":1792126087429,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T00:00:00Z","timestamp":1785196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.jdcr.2026.07.049","type":"journal-article","created":{"date-parts":[[2026,8,2]],"date-time":"2026-08-02T19:44:46Z","timestamp":1785699886000},"page":"161-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Refractory IgG4\u2212related skin disease successfully treated with intravenous methylprednisolone and baricitinib"],"prefix":"10.1016","volume":"76","author":[{"given":"Jacqueline","family":"Jiang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"McCormack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Veysey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda M.","family":"Saracino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jdcr.2026.07.049_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/art.41120","article-title":"The 2019 American College of Rheumatology\/European League Against Rheumatism Classification Criteria for IgG4-related disease","volume":"72","author":"Wallace","year":"2020","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.07.049_bib2","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/1346-8138.13723","article-title":"Immunoglobulin G4-related disease and its skin manifestations","volume":"44","author":"Takayama","year":"2017","journal-title":"J Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.07.049_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/modpathol.2012.196","article-title":"Clinicopathologic analysis of IgG4-related skin disease","volume":"26","author":"Sato","year":"2013","journal-title":"Mod Pathol"},{"issue":"1","key":"10.1016\/j.jdcr.2026.07.049_bib4","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jaad.2016.01.046","article-title":"Cutaneous manifestations of IgG4-related disease (RD): a systematic review","volume":"75","author":"Charrow","year":"2016","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"10.1016\/j.jdcr.2026.07.049_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2023-003498","article-title":"Diagnostic utility of serum IgG4 level in IgG4-related diseases: a comprehensive systematic review and meta-analysis","volume":"9","author":"Chang","year":"2023","journal-title":"RMD Open"},{"issue":"5","key":"10.1016\/j.jdcr.2026.07.049_bib6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1080\/1744666X.2021.1902310","article-title":"Emerging therapy options for IgG4-related disease","volume":"17","author":"Lanzillotta","year":"2021","journal-title":"Expert Rev Clin Immunol"},{"issue":"5","key":"10.1016\/j.jdcr.2026.07.049_bib7","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1111\/bjd.13296","article-title":"IgG4-related skin disease","volume":"171","author":"Tokura","year":"2014","journal-title":"Br J Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2026.07.049_bib8","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jaci.2020.10.022","article-title":"The emerging role of Janus kinase inhibitors in the treatment of autoimmune and inflammatory diseases","volume":"147","author":"Damsky","year":"2021","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"10.1016\/j.jdcr.2026.07.049_bib9","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1093\/mrcr\/rxae025","article-title":"A case of IgG4-related disease associated with ulcerative colitis that was successfully treated with a JAK inhibitor","volume":"8","author":"Tanaka","year":"2024","journal-title":"Mod Rheumatol Case Rep"},{"issue":"1","key":"10.1016\/j.jdcr.2026.07.049_bib10","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13075-025-03710-9","article-title":"Baricitinib ameliorates skin fibrosis via direct fibroblast suppression and endothelial exosome-mediated paracrine signaling","volume":"28","author":"Hou","year":"2025","journal-title":"Arthritis Res Ther"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004698?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512626004698?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T04:28:02Z","timestamp":1792124882000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512626004698"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":10,"alternative-id":["S2352512626004698"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.07.049","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Refractory IgG4\u2212related skin disease successfully treated with intravenous methylprednisolone and baricitinib","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2026.07.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}